INNOVUS PHARMACEUTICALS, INC. AMENDMENT TO 8% CONVERTIBLE DEBENTURE
EXHIBIT 10.2(b)
INNOVUS PHARMACEUTICALS, INC.
AMENDMENT TO 8% CONVERTIBLE DEBENTURE
THIS AMENDMENT TO 8% CONVERTIBLE DEBENTURE (“Amendment”) is entered into as of January 12, 2013 (the “Effective Date”), by and among Innovus Pharmaceuticals, Inc., a Nevada corporation ("Issuer"), and [ ] ("Debenture Holder").
RECITALS
WHEREAS, the signatories hereto are parties to that certain 8% Convertible Debenture dated January 13, 2012 (the “Debenture”).
WHEREAS, the signatories hereto desire to enter into this Amendment to amend the Debenture as set forth herein.
AGREEMENT
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto, intending legally to be bound, agree as follows:
| 1. | Amendment of Section 1.1(b). Section 1.1(b) of the Debenture is amended to replace the phrase “12 months from the date of the Debenture” with “January 14, 2014”. |
| 2. | Amendment to Section 3.1. Section 3.1 of the Debenture is amended to replace the phrase “the date that is 12 months from the date of the Debenture” with “January 14, 2014”. |
| 3. | Amendment to Section 4.2. Section 4.2 of the Debenture is amended to replace the phrase “If to Debenture Holder at its address as furnished on the face of this Debenture” with “If to Debenture Holder: |
_________________ [Name]
_________________ [Street Address]
_________________ [Street Address 2]
_________________ [City, State Country, Postal Code]
_________________ [Facsimile Number]
| 4. | Authority. Debenture Holder hereby represents and warrants that it is the sole legal and beneficial owner of the Debenture, and that no other person has any interest (other than a community property interest) in the Debenture. Each signatory below represents that he/she/it has the full authority to execute this Amendment, and no consents or approvals are required for such execution that have not been obtained prior to execution. |
| 5. | Ratification, No Default or Conversion. Debenture Holder hereby confirms (a) the absence of any Event of Default under the Debenture and (b) the absence of any conversion, pursuant to Section 1.2 or Section 3.1 of the Debenture, or otherwise. Except as amended herein, the Debenture shall remain in full force and effect. |
| 6. | Entire Agreement. This Amendment and Debenture constitute the entire agreement between the parties hereto and collectively supersede any prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof. |
| 7. | Conflict of Terms. In the event of any inconsistency between the provisions of this Amendment and any provision of the Debenture, the terms and provisions of this Amendment shall govern and control. |
IN WITNESS WHEREOF, the parties hereto have executed this Amendment to 8% Convertible Debenture on the date first above written.
INNOVUS PHARMACEUTICALS, INC.
By: _______________________________
Name:
Title:
DEBENTURE HOLDER
By: _______________________________
Name:
